Literature DB >> 18661557

Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.

Chrissandra J Zagami1, Philip M Beart, Nicole Wallis, Phillip Nagley, Ross D O'Shea.   

Abstract

In amyotrophic lateral sclerosis (ALS) non-neuronal cells play key roles in disease etiology and loss of motoneurons via noncell-autonomous mechanisms. Reactive astrogliosis and dysfunctional transporters for L-glutamate [excitatory amino acid transporters, (EAATs)] are hallmarks of ALS pathology. Here, we describe mechanistic insights into ALS pathology involving EAAT-associated homeostasis in response to a destructive milieu, in which oxidative stress and excitotoxicity induce respectively astrogliosis and motoneuron injury. Using an in vitro neuronal-glial culture of embryonic mouse spinal cord, we demonstrate that EAAT activity was maintained initially, despite a loss of cellular viability induced by exposure to oxidative [3-morpholinosydnonimine chloride (SIN-1)] and excitotoxic [(S)-5-fluorowillardiine (FW)] conditions. This homeostatic response of EAAT function involved no change in the cell surface expression of EAAT1/2 at 0.5-4 h, but rather alterations in kinetic properties. Over this time-frame, EAAT1/2 both became more widespread across astrocytic arbors in concert with increased expression of glial fibrillary acidic protein (GFAP), although at 8-24 h there was gliotoxicity, especially with SIN-1 rather than FW. An opposite picture was found for motoneurons where FW, not SIN-1, produced early and extensive neuritic shrinkage and blebbing (> or =0.5 h) with somata loss from 2 h. We postulate that EAATs play an early homeostatic and protective role in the pathologic milieu. Moreover, the differential profiles of injury produced by oxidative and excitotoxic insults identify two distinct phases of injury which parallel important aspects of the pathology of ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18661557     DOI: 10.1002/glia.20739

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  17 in total

Review 1.  Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.

Authors:  Kevin S Chen; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

Review 2.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

Review 3.  EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.

Authors:  Lauren Taylor Rosenblum; Davide Trotti
Journal:  Adv Neurobiol       Date:  2017

Review 4.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

5.  Transportable and non-transportable inhibitors of L-glutamate uptake produce astrocytic stellation and increase EAAT2 cell surface expression.

Authors:  Chew L Lau; Philip M Beart; Ross D O'Shea
Journal:  Neurochem Res       Date:  2010-02-09       Impact factor: 3.996

6.  13C NMR metabolomic evaluation of immediate and delayed mild hypothermia in cerebrocortical slices after oxygen-glucose deprivation.

Authors:  Jia Liu; Mark R Segal; Mark J S Kelly; Jeffrey G Pelton; Myungwon Kim; Thomas L James; Lawrence Litt
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

7.  Purinergic Modulation of Spinal Neuroglial Maladaptive Plasticity Following Peripheral Nerve Injury.

Authors:  Giovanni Cirillo; Anna Maria Colangelo; Miluscia Berbenni; Vita Maria Ippolito; Ciro De Luca; Francesco Verdesca; Leonilde Savarese; Lilia Alberghina; Nicola Maggio; Michele Papa
Journal:  Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.590

Review 8.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

Review 9.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

10.  Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.

Authors:  Charlotte Veyrat-Durebex; Philippe Corcia; Eric Piver; David Devos; Audrey Dangoumau; Flore Gouel; Patrick Vourc'h; Patrick Emond; Frédéric Laumonnier; Lydie Nadal-Desbarats; Paul H Gordon; Christian R Andres; Hélène Blasco
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.